Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Natural killer cell function in trisomy-21 (Down's syndrome).

T Nurmi, K Huttunen, O Lassila

    Clinical and Experimental Immunology
    |March 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Assessing the discharge instructing in the emergency department: Patient perspective.

    International emergency nursing·2018
    Same author

    BLIMP-1 is insufficient to induce antibody secretion in the absence of IRF4 in DT40 cells.

    Scandinavian journal of immunology·2018
    Same author

    Serum Concentrations of 25-Hydroxyvitamin D and Depression in a General Middle-Aged to Elderly Population in Finland.

    The journal of nutrition, health & aging·2018
    Same author

    Omega-6 polyunsaturated fatty acids, serum zinc, delta-5- and delta-6-desaturase activities and incident metabolic syndrome.

    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2017
    Same author

    Circulating Dendritic Cells, Farm Exposure and Asthma at Early Age.

    Scandinavian journal of immunology·2015
    Same author

    Exposure to a farm environment is associated with T helper 1 and regulatory cytokines at age 4.5 years.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015

    Individuals with trisomy-21 (Down syndrome) show altered natural killer (NK) cell activity. Their NK cells have reduced augmentation by interferon-alpha, potentially explaining increased infection and leukemia susceptibility.

    Area of Science:

    • Immunology
    • Human Genetics

    Background:

    • Natural killer (NK) cells and antibody-dependent cell-mediated cytotoxicity (ADCC) are crucial for immune surveillance against infections and malignancies.
    • Trisomy-21 (Down syndrome) is associated with immune dysregulation, but the specific role of NK cells remains unclear.

    Purpose of the Study:

    • To investigate NK cell activity and ADCC in adults with trisomy-21 compared to healthy controls.
    • To assess the effect of human leukocyte interferon-alpha (IFN-alpha) on NK cell activity in trisomy-21 and control groups.

    Main Methods:

    • Measurement of spontaneous and IFN-alpha-augmented NK activity and ADCC against K562 target cells.
    • Comparison between adult trisomy-21 patients and age/sex-matched controls.
    • Experiments were conducted with both whole lymphocytes and monocyte/macrophage-depleted lymphocytes.

    Related Experiment Videos

    Main Results:

    • Spontaneous NK activity was slightly higher in trisomy-21 patients but not statistically significant.
    • IFN-alpha significantly augmented NK activity in both groups when monocytes were present.
    • In monocyte-depleted lymphocytes, NK activity augmentation by IFN-alpha was impaired in trisomy-21 patients compared to controls.
    • ADCC correlated with NK activity in both groups.

    Conclusions:

    • Monocytes and macrophages appear to play a role in NK cell function and interferon response.
    • The deficient augmentation of NK cells by IFN-alpha in trisomy-21 individuals suggests a potential genetic disturbance in the NK cell/interferon system linked to chromosome 21.
    • This immune dysregulation may contribute to the increased susceptibility to infections and lymphatic leukemia observed in Down syndrome.